Ocrelizumab for relapsing-remitting multiple sclerosis

Authors
Category Structured summary of systematic reviews
JournalHTA Database
Year 2014
RECORD STATUS: This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. CITATION: NIHR HSC. Ocrelizumab for relapsing-remitting multiple sclerosis. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2014
Epistemonikos ID: ebbe46164b6840488a137615de2a21a845426ee4
First added on: Feb 06, 2015